US Stock MarketDetailed Quotes
TSHA Taysha Gene Therapies
- 2.8900
- +0.4200+17.00%
Close Nov 25 16:00 ET
- 2.8915
- +0.0015+0.05%
Post 19:46 ET
592.29MMarket Cap4.59P/E (TTM)
3.0300High2.4900Low9.97MVolume2.5000Open2.4700Pre Close28.85MTurnover7.91%Turnover RatioLossP/E (Static)204.94MShares4.320052wk High6.67P/B364.41MFloat Cap1.190052wk Low--Dividend TTM126.09MShs Float33.3500Historical High--Div YieldTTM21.86%Amplitude0.5000Historical Low2.8940Avg Price1Lot Size
Taysha Gene Therapies Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -4.01%157.69M | 283.17%172.74M | 95.47%123.98M | 63.79%143.94M | 63.79%143.94M | 378.86%164.28M | -31.94%45.08M | -34.36%63.43M | -41.06%87.88M | -41.06%87.88M |
| -Cash and cash equivalents | -4.01%157.69M | 283.17%172.74M | 95.47%123.98M | 63.79%143.94M | 63.79%143.94M | 378.86%164.28M | -31.94%45.08M | -34.36%63.43M | -41.06%87.88M | -41.06%87.88M |
| Prepaid assets | -32.90%2.95M | -68.31%2.47M | -56.52%3.34M | -65.89%2.51M | -65.89%2.51M | -42.05%4.4M | -15.43%7.8M | -12.30%7.68M | -19.18%7.35M | -19.18%7.35M |
| Restricted cash | --449K | --449K | --449K | --449K | --449K | ---- | ---- | ---- | --0 | --0 |
| Current deferred assets | --0 | -16.99%601K | -5.94%681K | -5.94%681K | -5.94%681K | 0.28%724K | 3.72%724K | 27.92%724K | 32.84%724K | 32.84%724K |
| Other current assets | 15.10%465K | -59.61%206K | -71.99%149K | -37.34%292K | -37.34%292K | 6.32%404K | -24.67%510K | -43.46%532K | -46.00%466K | -46.00%466K |
| Total current assets | -5.97%161.56M | 229.80%178.47M | 80.49%130.6M | 55.44%149.87M | 55.44%149.87M | 299.53%171.81M | -29.57%54.12M | -32.31%72.36M | -39.59%96.42M | -39.59%96.42M |
| Non current assets | ||||||||||
| Net PPE | -22.50%16.29M | -20.43%19.48M | -21.12%19.95M | -21.22%20.41M | -21.22%20.41M | -67.13%21.02M | -59.86%24.49M | -54.12%25.29M | -48.81%25.91M | -48.81%25.91M |
| -Gross PPE | -14.62%20.21M | -13.75%23.11M | -14.69%23.26M | -15.10%23.39M | -15.10%23.39M | -63.73%23.66M | -56.80%26.8M | -51.21%27.26M | -46.10%27.55M | -46.10%27.55M |
| -Accumulated depreciation | -48.09%-3.91M | -57.03%-3.63M | -67.82%-3.31M | -81.43%-2.98M | -81.43%-2.98M | -105.20%-2.64M | -127.46%-2.31M | -161.67%-1.97M | -229.06%-1.64M | -229.06%-1.64M |
| Other non current assets | -19.38%2.37M | -17.07%2.44M | -37.90%2.46M | -37.90%2.46M | -37.90%2.46M | -24.24%2.94M | -23.47%2.94M | 19.43%3.95M | 5.58%3.95M | 5.58%3.95M |
| Total non current assets | -22.12%18.66M | -20.07%21.92M | -23.39%22.4M | -23.43%22.86M | -23.43%22.86M | -65.00%23.96M | -58.12%27.43M | -50.51%29.24M | -45.07%29.86M | -45.07%29.86M |
| Total assets | -7.94%180.22M | 145.75%200.39M | 50.59%153M | 36.79%172.73M | 36.79%172.73M | 75.63%195.77M | -42.71%81.54M | -38.79%101.6M | -40.98%126.28M | -40.98%126.28M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -34.41%4.93M | -19.02%8.72M | 15.31%10.38M | -41.84%6.37M | -41.84%6.37M | -50.69%7.52M | -55.08%10.77M | -59.08%9M | -49.70%10.95M | -49.70%10.95M |
| -accounts payable | -34.41%4.93M | -19.02%8.72M | 15.31%10.38M | -41.84%6.37M | -41.84%6.37M | -50.69%7.52M | -55.08%10.77M | -59.08%9M | -49.70%10.95M | -49.70%10.95M |
| Current accrued expenses | -28.38%5.5M | -55.77%5.86M | -12.14%8.69M | -53.45%5.65M | -53.45%5.65M | -32.58%7.68M | 2.85%13.26M | -51.94%9.89M | -41.63%12.13M | -41.63%12.13M |
| Current debt and capital lease obligation | 18.01%1.82M | 7.08%1.75M | -3.20%1.7M | 8.22%1.65M | 8.22%1.65M | --1.54M | --1.64M | --1.75M | --1.52M | --1.52M |
| -Current capital lease obligation | 18.01%1.82M | 7.08%1.75M | -3.20%1.7M | 8.22%1.65M | 8.22%1.65M | --1.54M | --1.64M | --1.75M | --1.52M | --1.52M |
| Current deferred liabilities | -37.12%11.8M | -32.90%13.58M | -49.07%14.7M | -46.04%18.11M | -46.04%18.11M | --18.76M | --20.24M | --28.85M | --33.56M | --33.56M |
| Other current liabilities | -99.01%1.4M | 46.69%1.37M | 127.83%1.57M | 81.08%1.18M | 81.08%1.18M | 8,837.66%141.22M | -36.67%936K | -56.49%690K | -56.41%650K | -56.41%650K |
| Current liabilities | -83.74%29.34M | -32.51%34.18M | -29.05%38.64M | -41.46%36.76M | -41.46%36.76M | 444.53%180.45M | 17.90%50.64M | 12.01%54.46M | 21.34%62.79M | 21.34%62.79M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 5.33%60.72M | -3.30%55.97M | 1.59%59.01M | 1.80%59.46M | 1.80%59.46M | -8.88%57.65M | -8.40%57.88M | -8.00%58.09M | -7.43%58.41M | -7.43%58.41M |
| -Long term debt | 11.47%42.97M | -1.35%37.84M | 6.16%40.51M | 6.69%40.51M | 6.69%40.51M | 2.05%38.55M | 2.06%38.35M | 2.07%38.16M | 2.08%37.97M | 2.08%37.97M |
| -Long term capital lease obligation | -7.07%17.75M | -7.14%18.13M | -7.17%18.5M | -7.27%18.95M | -7.27%18.95M | -25.08%19.1M | -23.75%19.53M | -22.62%19.93M | -21.08%20.44M | -21.08%20.44M |
| Non current deferred liabilities | ---- | ---- | ---- | ---- | ---- | --2.95M | --6.21M | ---- | ---- | ---- |
| Other non current liabilities | -64.43%1.36M | -64.81%1.38M | -62.49%1.5M | -61.82%1.58M | -61.82%1.58M | -2.59%3.83M | 12.70%3.92M | 14.53%4M | 10.58%4.13M | 10.58%4.13M |
| Total non current liabilities | -3.64%62.09M | -15.68%57.35M | -2.54%60.51M | -2.40%61.04M | -2.40%61.04M | -4.12%64.43M | 2.02%68.02M | -6.81%62.09M | -6.42%62.54M | -6.42%62.54M |
| Total liabilities | -62.67%91.42M | -22.87%91.53M | -14.93%99.15M | -21.97%97.79M | -21.97%97.79M | 144.05%244.88M | 8.24%118.66M | 1.13%116.55M | 5.70%125.33M | 5.70%125.33M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 0.00%1K | --1K | --1K | --1K |
| -common stock | 0.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 100.00%2K | 0.00%1K | --1K | --1K | --1K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -4.06%-583.52M | -25.77%-558M | -28.16%-537.07M | -27.79%-513.01M | -27.79%-513.01M | -62.09%-560.75M | -38.80%-443.66M | -46.65%-419.06M | -70.36%-401.44M | -70.36%-401.44M |
| Paid-in capital | 31.86%674.64M | 63.44%664.46M | 46.29%591.17M | 46.11%587.94M | 46.11%587.94M | 43.29%511.63M | 15.38%406.55M | 20.10%404.11M | 21.56%402.39M | 21.56%402.39M |
| Gains losses not affecting retained earnings | ---2.33M | --2.41M | ---251K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total stockholders'equity | 280.80%88.8M | 393.33%108.87M | 460.24%53.85M | 7,796.42%74.94M | 7,796.42%74.94M | -541.43%-49.11M | -213.46%-37.11M | -129.47%-14.95M | -99.01%949K | -99.01%949K |
| Total equity | 280.80%88.8M | 393.33%108.87M | 460.24%53.85M | 7,796.42%74.94M | 7,796.42%74.94M | -541.43%-49.11M | -213.46%-37.11M | -129.47%-14.95M | -99.01%949K | -99.01%949K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
